A5029120688- Intensive Care Unit Cognitive Disorders
- Anesthesia and Sedative Agents
- Pharmaceutical Practices and Patient Outcomes
- Sleep and related disorders
- Long-Term Effects of COVID-19
- Antiplatelet Therapy and Cardiovascular Diseases
- Respiratory Support and Mechanisms
- Sleep and Wakefulness Research
- COVID-19 Clinical Research Studies
- Venous Thromboembolism Diagnosis and Management
- Thermal Regulation in Medicine
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac, Anesthesia and Surgical Outcomes
- Pharmaceutical studies and practices
- Antifungal resistance and susceptibility
- Pharmacological Effects and Toxicity Studies
- Health, Environment, Cognitive Aging
- Pharmacy and Medical Practices
- Pain Management and Placebo Effect
- Opioid Use Disorder Treatment
- Cancer Treatment and Pharmacology
- Anesthesia and Neurotoxicity Research
- Healthcare Decision-Making and Restraints
- Cardiac Arrest and Resuscitation
- Restless Legs Syndrome Research
University of Maryland Medical Center
2019-2025
University of Maryland, Baltimore
2019-2025
Dent Neurologic Institute
2020
University at Buffalo, State University of New York
2020
UPMC Presbyterian
2019
University of Pittsburgh Medical Center
2019
Introduction Data comparing sedatives in patients receiving extracorporeal membrane oxygenation (ECMO) are sparse. However, it is known that the ECMO circuit alters pharmacokinetic properties of medications via drug sequestration lipophilic agents and increased volume distribution. Objectives This study evaluated difference days alive without delirium or coma sedative requirements fentanyl versus hydromorphone patients. Methods single‐center retrospective observational adults for more than...
Abstract Introduction Aspirin and clopidogrel are mainstays in secondary stroke prevention; however, some patients do not demonstrate optimal antiplatelet effects from these therapies. Objectives The primary objective of this study was to determine if pharmacist medication intervention paired with anti‐platelet monitoring whole blood aggregometry improved responsiveness treatment when compared standard‐of‐care, alone at risk recurrent or transient ischemic attack (TIA). Methods This...
Background Currently, there is limited literature on the impact of COVID-19 infection medications and medical conditions in intensive care unit (ICU) survivors. Our study is, to our knowledge, first multicenter describe prevalence new medication changes at hospital discharge ICU Objective To determine number admission compared Methods Retrospective observational (7 ICUs) evaluated patients with admitted an between March 1, 2020, 2021. Patient characteristics, baseline conditions, length...
May 7, 2019April 9, 2019Free AccessEffect of L-methylfolate on Depressive Symptoms in Patients with MTHFR Mutations (P3.9-057)Michelle Rainka, Jacqueline Meaney, Erica S. Westphal, Traci Aladeen, Kaitlin Landolf, Sarah Stanford, Patrick Galdun, Natalie Asbach, Francis Gengo, and Horacio CapoteAuthors Info & AffiliationsApril 2019 issue92 (15_supplement)https://doi.org/10.1212/WNL.92.15_supplement.P3.9-057 Letters to the Editor
Landolf, Kaitlin1; Rivosecchi, Ryan2; Gomez, Hernando3; Sciortino, Christopher2; Holt, Murray2; Padmanabhan, Rajagopala4; Sanchez, Pablo2; Harano, Takashi2; Sappington, Penny5 Author Information
1University of Maryland Medical Center, Baltimore, MD 2University Pittsburgh Center Presbyterian, Pittsburgh, PA
1University of Maryland School Pharmacy, Baltimore, MD 2University Medical Center,
Heavner, Mojdeh; Cirelli, Abigail; Jobe, Sophia; Yeung, Siu Yan Amy; Landolf, Kaitlin; D’Silva, Shanholtz, Carl; Verceles, Avelino; Wickwire, Emerson Author Information
Introduction: Rates of substance use are high among critically ill trauma patients, and data regarding sedation analgesia requirements conflicting. The purpose this study is to compare sedative medication mechanically ventilated patients with or without a history (HOSU) within the first seven days intensive care unit (ICU) admission. We hypothesize that HOSU requires more medications control behavior than those HOSU. Methods: This retrospective cohort included adult if they were receiving...
Introduction: Pulmonary embolism (PE) remains a significant cause of morbidity and mortality, often due to right ventricular (RV) failure. vasodilators, such as inhaled nitric oxide (iNO) or epoprostenol (iEPO) may be used decrease RV afterload prevent failure in patients with submassive PE. Studies characterizing the use iEPO PE, including dose, duration, weaning, are lacking. The purpose this study was evaluate PE at our institution. Methods: This cohort retrospective chart review adult...
Landolf, Kaitlin1; Noh, Judy2; Devabhakthuni, Sandeep3; Heavner, Mojdeh4 Author Information